106 related articles for article (PubMed ID: 27906773)
21. Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
Ezra A; Rabinovich-Nikitin I; Rabinovich-Toidman P; Solomon B
J Alzheimers Dis; 2016; 50(1):175-88. PubMed ID: 26682687
[TBL] [Abstract][Full Text] [Related]
22. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
23. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.
García-Mesa Y; Pareja-Galeano H; Bonet-Costa V; Revilla S; Gómez-Cabrera MC; Gambini J; Giménez-Llort L; Cristòfol R; Viña J; Sanfeliu C
Psychoneuroendocrinology; 2014 Jul; 45():154-66. PubMed ID: 24845186
[TBL] [Abstract][Full Text] [Related]
24. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease.
St-Amour I; Bosoi CR; Paré I; Ignatius Arokia Doss PM; Rangachari M; Hébert SS; Bazin R; Calon F
J Neuroinflammation; 2019 Jan; 16(1):3. PubMed ID: 30611289
[TBL] [Abstract][Full Text] [Related]
25. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
26. Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.
Revilla S; Ursulet S; Álvarez-López MJ; Castro-Freire M; Perpiñá U; García-Mesa Y; Bortolozzi A; Giménez-Llort L; Kaliman P; Cristòfol R; Sarkis C; Sanfeliu C
CNS Neurosci Ther; 2014 Nov; 20(11):961-72. PubMed ID: 25119316
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.
Ye M; Chung HS; Lee C; Yoon MS; Yu AR; Kim JS; Hwang DS; Shim I; Bae H
J Neuroinflammation; 2016 Jan; 13():10. PubMed ID: 26772975
[TBL] [Abstract][Full Text] [Related]
28. Maternal genotype influences behavioral development of 3×Tg-AD mouse pups.
Blaney CE; Gunn RK; Stover KR; Brown RE
Behav Brain Res; 2013 Sep; 252():40-8. PubMed ID: 23711927
[TBL] [Abstract][Full Text] [Related]
29. Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.
Di Meco A; Joshi YB; Lauretti E; Praticò D
Mol Psychiatry; 2016 Mar; 21(3):403-10. PubMed ID: 26077691
[TBL] [Abstract][Full Text] [Related]
30. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
32. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
33. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
35. High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.
Tong Y; Yang H; Tian X; Wang H; Zhou T; Zhang S; Yu J; Zhang T; Fan D; Guo X; Tabira T; Kong F; Chen Z; Xiao W; Chui D
J Alzheimers Dis; 2014; 42(3):865-78. PubMed ID: 24961945
[TBL] [Abstract][Full Text] [Related]
36. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
[TBL] [Abstract][Full Text] [Related]
37. Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.
Qiu H; Zhong R; Liu H; Zhang F; Li S; Le W
J Alzheimers Dis; 2016; 50(3):669-85. PubMed ID: 26757041
[TBL] [Abstract][Full Text] [Related]
38. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
39. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
40. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
